Skip to main content
Caplight Logo









Suzhou NeuPharma Co., Ltd.

Suzhou NeuPharma Co., Ltd.

Private
SuzhouHealthcare & Life Scienceshttps://neupharma.com/

Last Round

Series B

Extension

Dec 14, 2018

Company Overview

Suzhou NeuPharma Co., Ltd. is a biopharmaceutical company that engages in the research and development of innovative medicines for unmet medical needs, with a focus on anti-cancer therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

small molecule drugstargeted cancer therapyoncology pipelineclinical stage biotechdrug discoveryprecision oncologyEGFR inhibitorBRAF inhibitornon-small cell lung cancerNSCLCdrug licensingcancer drug resistancesolid tumor therapyNa+/K+-ATPase inhibitor

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Suzhou NeuPharma Co., Ltd. Comparables

Compare Suzhou NeuPharma Co., Ltd. with similar companies based on industry and business-model similarity.

Suzhou NeuPharma Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ABM Therapeutics
81%
Shanghai Henlius Biotech Inc
78%
Innovent Biologics
77%

Suzhou NeuPharma Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionDec 14, 2018
Series BJun 28, 2018

Suzhou NeuPharma Co., Ltd. Investors

Notable investors and investment history

Suzhou NeuPharma Co., Ltd. investors
InvestorRounds
China Science and Technology Industry Investment ManagementSeries B Extension
Longwater InvestmentSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2026

    Monthly visitors increased 120% MoM.

  • Nov 8, 2024

    Monthly visitors increased 252% MoM.

Suzhou NeuPharma Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Suzhou NeuPharma Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Suzhou NeuPharma Co., Ltd.'s valuation, stock price, and market status.

Is Suzhou NeuPharma Co., Ltd. a public or private company?

Suzhou NeuPharma Co., Ltd. is a private company.

What is the current stock price of Suzhou NeuPharma Co., Ltd.?

Suzhou NeuPharma Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Suzhou NeuPharma Co., Ltd. worth (valuation)?

Valuation information for Suzhou NeuPharma Co., Ltd. is not publicly available.

Can I buy Suzhou NeuPharma Co., Ltd. stock?

Suzhou NeuPharma Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Suzhou NeuPharma Co., Ltd.'s last funding round?

Suzhou NeuPharma Co., Ltd.'s most recent funding round was Series B Extension on December 14, 2018.

Who are the main investors in Suzhou NeuPharma Co., Ltd.?

Key investors in Suzhou NeuPharma Co., Ltd. include China Science and Technology Industry Investment Management, Longwater Investment.

Will Suzhou NeuPharma Co., Ltd. IPO soon?

No public IPO plans have been announced for Suzhou NeuPharma Co., Ltd..

How can I track Suzhou NeuPharma Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Suzhou NeuPharma Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSuzhou
Employee Range1
Year Founded2009
Last FundingDec 14, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?